St. Jude Medical, Inc. Third Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component St. Jude Medical, Inc. (NYSE:STJ) will unveil its latest earnings on Wednesday, October 19, 2011. St. Jude Medical develops, manufactures and distributes cardiovascular medical devices.

St. Jude Medical, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 76 cents per share, a rise of 5.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 80 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 76 cents during the last month. For the year, analysts are projecting profit of $3.27 per share, a rise of 8.6% from last year.

Past Earnings Performance: Last quarter, the company beat estimates by one cent, coming in at net income of 85 cents a share versus the estimate of profit of 84 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: Analysts are projecting a rise of 10.5% in revenue from the year-earlier quarter to $1.37 billion.

Analyst Ratings: Analysts are bullish on this stock with 21 analysts rating it as a buy, one rating it as a sell and 13 rating it as a hold.

A Look Back: In the second quarter, profit fell 5.2% to $240.9 million (72 cents a share) from $254 million (77 cents a share) the year earlier, but exceeded analyst expectations. Revenue rose 10.2% to $1.45 billion from $1.31 billion.

Key Stats:

Revenue has risen the past four quarters. Revenue rose 9% in the first quarter from the year earlier, climbed 12.2% in the fourth quarter of the last fiscal year from the year-ago quarter and 6.9% in the third quarter of the last fiscal year.

The company has seen net income fall in each of the last two quarters. Net income dropped 2.2% in the first quarter.

Competitors to Watch: Medtronic, Inc. (NYSE:MDT), Boston Scientific Corp. (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Hansen Medical, Inc. (NASDAQ:HNSN), Greatbatch Inc. (NYSE:GB), Cardima, Inc. (CADMQ), AtriCure Inc. (NASDAQ:ATRC), Volcano Corporation (NASDAQ:VOLC), C.R. Bard, Inc. (NYSE:BCR), and Stereotaxis, Inc. (NASDAQ:STXS).

Stock Price Performance: During July 20, 2011 to October 13, 2011, the stock price had fallen $9.27 (-19.5%) from $47.55 to $38.28. The stock price saw one of its best stretches over the last year between February 4, 2011 and February 14, 2011 when shares rose for seven-straight days, rising 13% (+$5.36) over that span. It saw one of its worst periods between July 21, 2011 and August 2, 2011 when shares fell for nine-straight days, falling 11.6% (-$5.70) over that span. Shares are down $3.87 (-9.2%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.